Medtronic (NYSE:MDT) has reportedly acquired gastrointestinal disorder diagnostic company Crospon in a deal that could be worth as much as $45 million (EU €38 million), according to a Times UK report. The Galway, Ireland-based developer was founded in 2006 by current chief exec John O’Dea, and is looking to develop tools to more effectively examine and […]
Endoscopic diagnostic company Crospon said today it won FDA 510(k) clearance for its next-gen Endoflip system with Flip topography module, designed to allow clinicians to assess patient motility disorders during endoscopy. The newly cleared Endoflip 2.0 system includes imaging software that displays esophageal contractility patterns in real time on a touch screen display, the Ireland-based […]
Irish medical device maker Crospon entered the gastroenterology market with FDA clearance to expand its EndoFlip imaging device to esophageal procedures.
The EndoFlip device is a functional lumen imaging probe used to measure the dimensions and function of hollow organs.
The system was previously cleared for use in during gastric band and sleeve gastrectomy bariatric surgery.